SOLARA.NSE

Solara Active Pharma Sciences Ltd.

In this briefing: PolyPeptide: Strategic Review Is Real, But the Setup Isn’t Clean Aequitas: Integris Medtech Ltd Pre-IPO: Medtech Platform with Strong Growth but Elevated Leverage Tetratherix Limited - Commercialising the Platform Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 1. PolyPeptide: Strategic Review Is Real, But the Setup Isn’t Clean PolyPeptide is in a credible strategic review process, but at CHF37.25 the market already prices a 58.3% deal probability, leaving limited upside relative to downside risk in a break scenario. While a full re-rating implies valuation above CHF 50, sponsor return constraints anchor a realistic takeout in the low-to-mid 40s, supported by LBO analysis and peer multiple comparisons. The controlling shareholder structure introduces a third outcome where minorities may not receive a full premium, meaning “a deal” does not necessarily translate into immediate value crystallisation for investors. 2. Aequitas: Integris Medtech Ltd Pre-IPO: Medtech Platform with Strong Growth but Elevated Leverage Integris Medtech Limited (1234518D IN) (IML) plans to raise around US$340m in its upcoming IPO.

In this briefing: Tetratherix Limited - Commercialising the Platform Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 Sirius (靖因生物) Pre-IPO: Pipeline Prioritization and Competitor Updates TransThera Placement (2617 HK): Tinengotinib Alone Can’t Signal Any Major Upheaval of Fortunes 1. Tetratherix Limited - Commercialising the Platform Tetratherix Limited (ASX:TTX) is an Australian biomedical company commercialising a proprietary polymer platform, Tetramatrix, across four franchises: bone regeneration, tissue spacing, tissue healing and precision medicine. Tetramatrix is a novel fully synthetic, water-based injectable polymer that transitions from a liquid to a solid matrix/scaffold when it enters the human body (at 37°C). As the product mimics natural tissue, it offers potential advantages versus existing animal-derived solutions that are prone to immune responses like inflammation. 2. Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing early signs of a turnaround with improved profitability and cash flows in the most recent fiscal year.

In this briefing: Tetratherix Limited - Commercialising the Platform Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 Sirius (靖因生物) Pre-IPO: Pipeline Prioritization and Competitor Updates TransThera Placement (2617 HK): Tinengotinib Alone Can’t Signal Any Major Upheaval of Fortunes 1. Tetratherix Limited - Commercialising the Platform Tetratherix Limited (ASX:TTX) is an Australian biomedical company commercialising a proprietary polymer platform, Tetramatrix, across four franchises: bone regeneration, tissue spacing, tissue healing and precision medicine. Tetramatrix is a novel fully synthetic, water-based injectable polymer that transitions from a liquid to a solid matrix/scaffold when it enters the human body (at 37°C). As the product mimics natural tissue, it offers potential advantages versus existing animal-derived solutions that are prone to immune responses like inflammation. 2. Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing early signs of a turnaround with improved profitability and cash flows in the most recent fiscal year.

In this briefing: Primer: Page Industries (PAG IN) - Apr 2026 Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Primer: Vedant Fashions (MANYAVAR IN) - Apr 2026 Aequitas: Rentmojo Ltd Pre-IPO Tearsheet Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 1. Primer: Page Industries (PAG IN) - Apr 2026 Market Leader with a Strong Brand Moat: Page Industries is the dominant player in the Indian premium innerwear and athleisure market, primarily through its long-term, exclusive license for the Jockey brand, which has been extended until 2040. This strong brand recognition and perceived quality command premium pricing and foster high consumer loyalty. Extensive and Evolving Distribution Network: The company possesses a formidable pan-India distribution network, including over 1,450 exclusive brand outlets (EBOs) and more than 125,000 retail touchpoints. Continuous expansion into Tier-2 and Tier-3 cities, coupled with a growing e-commerce presence, provides a robust platform for future growth.

In this briefing: Primer: Page Industries (PAG IN) - Apr 2026 Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Primer: Vedant Fashions (MANYAVAR IN) - Apr 2026 Aequitas: Rentmojo Ltd Pre-IPO Tearsheet Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 1. Primer: Page Industries (PAG IN) - Apr 2026 Market Leader with a Strong Brand Moat: Page Industries is the dominant player in the Indian premium innerwear and athleisure market, primarily through its long-term, exclusive license for the Jockey brand, which has been extended until 2040. This strong brand recognition and perceived quality command premium pricing and foster high consumer loyalty. Extensive and Evolving Distribution Network: The company possesses a formidable pan-India distribution network, including over 1,450 exclusive brand outlets (EBOs) and more than 125,000 retail touchpoints. Continuous expansion into Tier-2 and Tier-3 cities, coupled with a growing e-commerce presence, provides a robust platform for future growth.

In this briefing: Primer: Page Industries (PAG IN) - Apr 2026 Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Primer: Vedant Fashions (MANYAVAR IN) - Apr 2026 Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 1. Primer: Page Industries (PAG IN) - Apr 2026 Market Leader with a Strong Brand Moat: Page Industries is the dominant player in the Indian premium innerwear and athleisure market, primarily through its long-term, exclusive license for the Jockey brand, which has been extended until 2040. This strong brand recognition and perceived quality command premium pricing and foster high consumer loyalty. Extensive and Evolving Distribution Network: The company possesses a formidable pan-India distribution network, including over 1,450 exclusive brand outlets (EBOs) and more than 125,000 retail touchpoints. Continuous expansion into Tier-2 and Tier-3 cities, coupled with a growing e-commerce presence, provides a robust platform for future growth.

In this briefing: Primer: Page Industries (PAG IN) - Apr 2026 Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Primer: Vedant Fashions (MANYAVAR IN) - Apr 2026 Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 1. Primer: Page Industries (PAG IN) - Apr 2026 Market Leader with a Strong Brand Moat: Page Industries is the dominant player in the Indian premium innerwear and athleisure market, primarily through its long-term, exclusive license for the Jockey brand, which has been extended until 2040. This strong brand recognition and perceived quality command premium pricing and foster high consumer loyalty. Extensive and Evolving Distribution Network: The company possesses a formidable pan-India distribution network, including over 1,450 exclusive brand outlets (EBOs) and more than 125,000 retail touchpoints. Continuous expansion into Tier-2 and Tier-3 cities, coupled with a growing e-commerce presence, provides a robust platform for future growth.

In this briefing: Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Primer: Vedant Fashions (MANYAVAR IN) - Apr 2026 Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 1. Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Arvind Fashions holds a strong position in India's apparel market through a focused portfolio of high-recognition, premium, and bridge-to-luxury brands, most notably the licensed brand U.S. Polo Assn., which is a significant revenue driver. The company is pursuing a clear growth strategy centered on expanding its retail footprint via an asset-light franchise model, enhancing its omnichannel capabilities, and growing its direct-to-consumer (D2C) business to improve margins and customer engagement. After a period of portfolio rationalization and financial volatility, the company has shown signs of a turnaround with improving profitability metrics and a strengthened balance sheet, although it faces intense competition and risks associated with licensed brand agreements.

In this briefing: Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Primer: Vedant Fashions (MANYAVAR IN) - Apr 2026 Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 1. Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Arvind Fashions holds a strong position in India's apparel market through a focused portfolio of high-recognition, premium, and bridge-to-luxury brands, most notably the licensed brand U.S. Polo Assn., which is a significant revenue driver. The company is pursuing a clear growth strategy centered on expanding its retail footprint via an asset-light franchise model, enhancing its omnichannel capabilities, and growing its direct-to-consumer (D2C) business to improve margins and customer engagement. After a period of portfolio rationalization and financial volatility, the company has shown signs of a turnaround with improving profitability metrics and a strengthened balance sheet, although it faces intense competition and risks associated with licensed brand agreements.